Evaluation of the von Willebrand factor Y1584C polymorphism as a potential risk factor for bleeding in patients receiving anticoagulant treatment with vitamin K antagonists

Authors

  • P. TJERNBERG,

    1. Hemostasis and Thrombosis Research Center, Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands; and Laboratory for Experimental Internal Medicine, Academic Medical Center, Amsterdam, the Netherlands
    Search for more papers by this author
  • J. F. VAN DER HEIJDEN,

    1. Hemostasis and Thrombosis Research Center, Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands; and Laboratory for Experimental Internal Medicine, Academic Medical Center, Amsterdam, the Netherlands
    Search for more papers by this author
  • J. C. J. EIKENBOOM,

    1. Hemostasis and Thrombosis Research Center, Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands; and Laboratory for Experimental Internal Medicine, Academic Medical Center, Amsterdam, the Netherlands
    Search for more papers by this author
  • P. H. REITSMA

    1. Hemostasis and Thrombosis Research Center, Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands; and Laboratory for Experimental Internal Medicine, Academic Medical Center, Amsterdam, the Netherlands
    Search for more papers by this author

J. C. J. Eikenboom, Hemostasis and Thrombosis Research Center, Department of Hematology, C2-R, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, the Netherlands.
Tel.: +31 71 526 2267; fax: +31 71 526 6755; e-mail: h.c.j.eikenboom@lumc.nl

No abstract is available for this article.

Ancillary